Improving Medication Access to Help Impact More Patients
Barriers to Medication Access
More than 320 million prescriptions are rejected each year due to medication access challenges like prior authorization (PA). Of those, more than 40% or 128 million prescriptions are abandoned. 1 Such access challenges also delay time to therapy, with some patients waiting 3 – 6 weeks for specialty therapies in some cases. 1
When patients cannot access the medication they were prescribed, providers must decide between spending precious time on paperwork or switching therapy.
Rejected claims result in lost scripts and your brand being perceived as difficult to prescribe.
The difficulty of the medication access process can vary based on the complexity and expense of prescribed medications. Together, CoverMyMeds’ solutions can address unique access challenges for any medication, and we work with life science manufacturers to further our objective of helping patients get the medication they need to live healthy lives.
We do that by guiding patients and providers through healthcare challenges – using technologies like electronic prior authorization (ePA), prescription decision support (PDS) and end-to-end support for specialty medications to help patients get the medications their providers have prescribed to them.

Decrease Abandonment
Without CoverMyMeds, 62 percent of rejected prescriptions are lost at the pharmacy. 2
Increase Paid Rates
When partnering with us, a brand is 46 percent more likely to be paid.
Decrease Turn Around Times
For specialty products, ePA reduces time to therapy from more than 17 days to as few as 1.5 days. 4
CoverMyMeds is Your Prescription Resolution Partner
With the nation’s largest ePA network, CoverMyMeds helps ease the administrative burden, quieting office noise and reinforcing positive perceptions of access leading to improved script writing for over 200 brands. Our solutions offer support through all stages of your brand’s life cycle, starting at launch through loss of exclusivity (LOE). Sponsored brands have seen an improvement in:
Volume of dispensed prescriptions
Fewer scripts are lost to switches or attrition due to complex policies and procedures. 2
Quality of prior authorization requests
The streamlined PA process results in a higher paid rate than when PA requests are submitted through other channels.
Improved script writing momentum
When barriers to access are decreased, or removed, providers are less likely to switch a script to an alternative medication and more likely to proceed with their original, preferred drug choice.
Who We Help
Patients
Patients
With CoverMyMeds, patients awaiting treatment were 12 to 14% more likely to receive their medication and waited less than 48 hours on average to receive a coverage determination.
Brands
Brands
CoverMyMeds is the leading prescription resolution network. To date, we’ve helped patients get the medication they need to live healthy lives over 150 million times.
As a partner to your brand, we’ll leverage our network — the largest in the industry — to help increase awareness of coverage support. This leads to more scripts filled, and better patient adherence.
Because of improved coverage awareness, CoverMyMeds partner brands achieve a 25% average increase in new prescriptions.
Providers
Providers
CoverMyMeds helps create a streamlined workflow, leading to improved perception of product access and stronger script writing momentum for the 900,000 providers within our network.
Get in Touch
More than 650 life science brands across retail and specialty trust CoverMyMeds to support their medication adherence and market access strategic imperatives.
Contact us to learn more about the benefits of partnering with CoverMyMeds.
Upcoming Events
- ePA National Adoption Scorecard
- CoverMyMeds data